Canopy Growth Making Progress in the Cannabis Sector

Shareholders finally approved Canopy Growth ’s deal to buy the U.S. marijuana company Acreage Holdings. The acquisition won’t happen until Congress makes the growth, sale, and possession of pot federally legal, or at least permissible in states that allow the drug.

But when that time comes, Canopy will have a “significant competitive advantage” over its Canadian peers, according to an analyst at Stifel.

The back story. Canopy (ticker: CGC) was already one of Canada’s biggest cannabis growers. It has received significant investment from Constellation Brands (STZ), and has a market value is north of $14 billion. The stock has gained 60% in 2019.

Read the full article at Barron's.

Don’t Stop Here

More To Explore

RVMD: Key Data on Daraxonrasib at AACR 2026!

Introduction Revolution Medicines, Inc. (NASDAQ: RVMD) is a late-stage oncology biotech focused on targeting RAS-driven cancers (marketchameleon.com) (www.biospace.com). The company’s lead drug daraxonrasib (also known

Markets Rebound Amid AI Boom and Water Crisis

Opening Recap Market Pulse: Equities bounced back into record territory as major indexes reclaimed pre-Iran conflict levels. Key Movers: AMC Robotics stunned Wall Street with